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496a Tuesday, February 23, 2010Methods: DRG from newborn Wistar rats were treatead with trypsin and me-
chanically dissociated. The cells were cultivated on poli-L-lysine-treated glass
slips. The culture was kept in DMEM with 5% fetal bovine serum, at 37C and
under 5% CO2 atmosphere. Changes in intracellular free-Ca2þ concentration
([Ca2þ]i) were evaluted in a confocal laser scanning microscope (Zeiss, LSM
510), using Fluo-4 (Molecular Probes) as a calcium indicator. Time series were
recorded in control conditions and during the exposure to the putative agonist.
Results: ATP 0.1 mM promoted transitory increases in the [Ca2þ]i in SGC
(94.4%, n=18) even in free-Ca2þ medium (81,3%, n=32). The P2Y agonists
ADP 0.1 mM, UTP 1 mM and UDP 1 mM promoted oscillations in 93.1%
(n=54), 15.6% (n=32) and 38.1% (n=42) of the SGC, respectively. Like
ADP, the MRS2365 0.1 mM, a selective P2Y1 agonist, promoted Ca2þ in-
crease (91.6 %, n=12). Previous application of MRS2365 blunts the response
of the SGC to BzATP 25mM (n=6), an agonist of P2X7 receptor.
Conclusions: The SGC from DRG express P2Y and P2X7 receptors. The ADP
sensitive subtype (P2Y1) predominates. A fraction of the observed SGC ex-
presses the UDP sensitive subtype (P2Y6), and a yet smaller fraction expresses
the UTP sensitive subtype (P2Y2 and/or P2Y4). Previous activation of the
P2Y1 receptor drastically reduces cell responses to BzATP, probably by down-
regulation of P2X7 ionotropic receptor.
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GSK3-b Inhibition is Involved in Testosterone-Induced Cardiac
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Glycogen Synthase Kinase 3-b (GSK3-b) is a negative regulator for cardiac hy-
pertrophy. This kinase controls protein synthesis mainly via activation of both
the translation initiation factor eIF2Be and the transcription factor NFAT. Tes-
tosterone induces cardiomyocyte hypertrophy, but if GSK3-b participates in
this event is unknown. Here we have studied whether the inhibition of
GSK3-b is involved in testosterone-induced cardiac hypertrophy.
Testosterone (100 nM) inhibited GSK3-b (phosphorylation increase at Ser9)
and activated the factor eIF2Be (phosphorylation decrease at Ser539). More-
over, pharmacological inhibition of GSK3-b by 1-azakenpaullone (10 mM) in-
creases the hormone-induced eIF2Be activation.
GSK3-b inhibition can be mediated by PI3K/Akt or MEK/ERK1/2 pathways.
PI3K/Akt inhibitors LY-292002 (1 mM) and Akt-inhibitor-VIII (10 mM)
blocked the testosterone-induced GSK3-b phophorylation, whereas ERK1/2 in-
hibitor (PD98059 50 mM) had not effect. NFAT is well characterized down-
stream target for GSK3-b. Testosterone increased the NFAT-luc activity and
this was blocked by NFAT inhibitors CsA (1 mM) and FK506 (1 mM). More-
over, GSK3-b inhibition increased NFAT activity.
In order to investigate the GSK3-b/NFAT contribution to testosterone-induced
hypertrophy, we evaluate the expression of skeletal a-actin (SKA). Testoster-
one and 1-azakenpaullone increased SKA expression while NFAT inhibition
blocked the testosterone-induced SKA increases.
These results suggest that testosterone-induced cardiomyocyte hypertrophy in-




Tingling Alkylamides from Echinacea Activate Somatosensory Neurons
Kristin A. Gerhold, Diana M. Bautista.
Univ California, Berkeley, Berkeley, CA, USA.
Extracts of Echinacea plants induce intense tingling paresthesia and numbing
analgesia when applied orally. Currently, there is little information regarding
the cellular or molecular mechanisms by which Echinacea produces its somato-
sensory effects. We characterized the ability of Echinacea extracts to activate
somatosensory neurons in vitro. Crude extracts induce a rise in intracellular cal-
cium in a subset of somatosensory neurons (49.056.2%), as measured by ra-
tiometric calcium imaging. In addition, application of Echinacea extract during
whole-cell current-clamp recording triggers depolarization of the resting mem-
brane potential, followed by action potential firing. Both the crude extract and
the purified alkylamide, Dodeca-2E, 4E- dienoic acid isobutylamide (E2), ac-
tivate a unique subset of somatosensory neurons that includes a large popula-
tion of putative light touch receptors. Whole-cell voltage clamp recording
shows that E2 blocks a background potassium current (28.053.8% inhibition
at 50mV; reversal potential¼51.8,52.5), in 56% of somatosensory neurons.
Interestingly, we find that E2 also inhibits voltage gated sodium currents in
57% of neurons (44.655.1% inhibition at x 20mV). We propose a model
in which Dodeca-2E, 4E- dienoic acid isobutylamide induces tingling paresthe-sia by inhibition of background potassium currents and numbing analgesia by
blocking voltage-gated sodium channels.
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Inhibition of cAMP-Dependent Protein Kinase (PKA) Activates b2-Adren-
ergic Receptor (b2-AR) Stimulation of Cytosolic Phospholipase A2 (cPLA2)
in Atrial Myocytes
Mallikarjuna R. Pabbidi, Xiang Ji, Allen M. Samarel, Stephen L. Lipsius.
Loyola University Medical Center, Maywood, IL, USA.
We reported that attachment of atrial myocytes to laminin (LMN) decreases ad-
enylate cyclase (AC)/cAMP and increases b2-AR stimulation of L-type Ca
2þ
current (ICa,L). This study determined whether LMN enhances b2-AR signaling
via a cAMP-independent mechanism, i.e. cPLA2 signaling. Atrial myocytes
were plated on uncoated cover-slips (-LMN) or cover-slips coated with LMN
(þLMN) (>2 hrs). As previously reported, 0.1 mM zinterol (b2-AR agonist)
stimulation of ICa,L was larger in þLMN than -LMN myocytes. In þLMN my-
ocytes, zinterol stimulation of ICa,L was inhibited by 10 mM AACOCF3 (cPLA2
inhibitor), pertussis toxin or 10 mM BAPTA-AM (intracellular Ca2þ chelator).
Stimulation of ICa,L by fenoterol (b2-AR/Gs agonist) was smaller in þLMN
than -LMN myocytes. Arachidonic acid (AA; 5 mM) stimulated ICa,L
in -LMN and þLMN myocytes similarly. Inhibition of PKA by either 5 mM
H-89 or 1 mM KT5720 in -LMN myocytes mimicked the effects of þLMN
myocytes to enhance zinterol stimulation of ICa,L, which was blocked by
AACOCF3. In contrast, H-89 inhibited fenoterol stimulation of ICa,L, which
was unchanged by AACOCF3. Inhibition of ERK1/2 by 1 mM U-0126 inhibited
zinterol stimulation of ICa,L in þLMN myocytes and -LMN myocytes in which
PKA was inhibited (KT5720). Western blots showed that inhibition of PKA
(KT5720) in -LMN myocytes markedly increased zinterol phosphorylation of
ERK1/2. We conclude that inhibition of AC/cAMP/PKA by cell attachment
to LMN or PKA by pharmacological agents in -LMN myocytes switches
b2-AR signaling from predominantly Gs/AC/cAMP/PKA to Gi/ERK1/2/
cPLA2/AA. These findings may be relevant to the remodeling of b-AR signal-
ing in diseased (fibrotic) and/or aging atria, both of which exhibit decreases in
AC activity.
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We reported that inhibition of adenylate cyclase (AC)/cAMP by cell attachment
to laminin (þLMN) or pharmacological (KT5720) inhibition of cAMP-depen-
dent protein kinase (PKA) in cells not attached to LMN (-LMN-PKA), activates
b2-AR stimulation of ICa,L via cPLA2 signaling. The present study determined
the role of PKC and IP3-mediated Ca
2þ release in b2-AR/cPLA2 signaling. As
previously reported, 0.1 mM zinterol (b2-AR agonist) stimulation of L-type
Ca2þ current (ICa,L) was unaffected by 10 mM AACOCF3 (cPLA2 inhibitor) in
cells not attached to LMN (-LMN) but was significantly inhibited in þLMN
and -LMN-PKA myocytes. Zinterol stimulation of ICa,L in -LMN
-PKA myocytes
was blocked by 5 mM U73122 (PLC inhibitor) and significantly inhibited by
4 mM chelerythrine (PKC inhibitor). Zinterol stimulation of ICa,L in -LMN my-
ocytes was unaffected by inhibition of IP3-receptors (IP3Rs) by 2 mM 2-APB, but
was significantly inhibited inþLMN and -LMN-PKA myocytes. Cells were cul-
tured on LMN (24 hrs) with an adenovirus IP3 affinity trap to inhibit IP3-depen-
dent Ca2þ signaling. Compared to control cells (b-gal), zinterol stimulation of
ICa,L was significantly inhibited in cells infected with IP3 trap. Laser scanning
confocal microscopy (fluo-4) revealed that zinterol stimulation ofþLMN myo-
cytes elicited local intracellular Ca2þ release events in 1 mM tetracaine (blocks
RyR Ca2þ release), that were blocked by 2-APB. We conclude that inhibition of
cAMP/PKA activates b2-AR stimulation of ICa,L via cPLA2 which is dependent
on PKC and IP3-mediated Ca
2þ signaling. These findings may be relevant to the
remodeling of b-AR signaling in diseased (fibrotic) and/or aging atria, both of
which exhibit decreases in AC activity.
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How does Adenosine Alter Sperm Motility?
Lindsey A. Burnett1, Jashvant D. Unadkat1, Bertil Hille1, Stephen Tilley2,
Donner F. Babcock1.
1University of Washington, Seattle, WA, USA, 2University of
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Adenosine is a candidate modulator of motility of spermatozoa as they progress
through the female reproductive tract. Past work demonstrated that the adenosine
analog 2-chloro-deoxyadenosine (Cl-dAdo) accelerates the flagellar beat rate of
Tuesday, February 23, 2010 497amouse sperm by a cAMP/PKA-mediated pathway with a pharmacological pro-
file suggestive of a Slc29a (ENT) equilibrative nucleoside transporter. Using
qRT-PCR we find in adult mouse testis 160- and 32-fold greater expression of
Slc29a1 than of the other surface-membrane ENT transporters Slc29a4 and
Slc29a2. However, Slc29a1 protein was not found on mature sperm using immu-
nocytochemistry. Moreover, wildtype and Slc29a1-null mice accelerate at sim-
ilar rates (1.5-2.0 Hz min1) in response to Cl-dAdo indicating that Slc29a1 is
not required for Cl-dAdo action. Consistent with this observation, the accelerat-
ing action of Cl-dAdo resists the Slc29a-selective inhibitor nitrobenzylthioino-
sine (NBTI; 10 mM). The accelerating action of Cl-dAdo additionally resists
replacement of external Naþwith NMDGþ indicating that Slc28a concentrative
nucleoside transporters (CNTs) also are not required. Interestingly, the Adeno-
sine A3 receptor-selective agonist Cl-IB-MECA (25mM) is nearly as effective as
Cl-dAdo in accelerating sperm beat frequency, suggesting a possible role for cell
surface A3 receptors in Cl-dAdo-mediated increases in sperm motility. Two A3
isoforms are expressed in the mouse Adora3i1 and Adora3i2; Adora3i2 expres-
sion is testis specific. Adora3i1 null sperm increase beat frequency in response to
both Cl-IB-MECA (25 mM) and Cl-dAdo (25 mM), so this isoform is not needed
for sperm response to adenosine. Sperm response to Cl-dAdo and Cl-IB-MECA
is diminished after pertussis toxin treatment of cells suggesting the receptor is
Gai/o coupled. We are currently testing functionality of the testis-specific novel
Adora3i2 isoform in a heterologous system. Support from U54-HD12629 of the
SCCPRR program of NICHD. L.A.B. supported in part by 5-T32-HD007453.
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Novel Receptor-Mediated Endothelial Cell Chemotaxis
Amir Shamloo, Frank Kuhnert, Vir Choksi, Calvin Kuo, Sarah Heilshorn.
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The directed migration of endothelial cells away from existing blood vessels is
a critical step during cancer progression. Specific receptor-ligand interactions
initiate intracellular signal transduction pathways and asymmetric cytoskeletal
reorganization, leading to migration towards ligand sources. Disruption of these
receptor-ligand interactions is a common goal in cancer drug development, and
a key hurdle is the discovery of new receptor-ligand partners that are suitable tar-
gets. The G-protein-coupled receptor 124 (GPR124) is enriched in the endothe-
lium of the developing brain and regulates embryonic CNS angiogenesis; how-
ever, its ligand and its potential role in endothelial cell chemotaxis are unknown.
We examined the migration of mouse brain-derived endothelial cells (bEnd3)
within custom microfluidic devices capable of generating stable concentration
gradients of chemotactic ligands. The bEnd3 were genetically modified either
to overexpress (GPR124þ) or knock down (GPR124-) receptor expression.
GPR124þ cells were observed to chemotax in response to a 0.025% gradient/
micron of embryonic brain cortical cell conditioned medium (CM), while
GPR124- cells followed random walk statistics in identical gradients. Mathemat-
ical analysis of the cell migration pathways (n~100 for each condition) revealed
that net migration displacement, migration persistence time, and migration speed
were increased for GPR124þ cells over GPR124- cells in both CM gradients as
well as uniform CM concentrations. This suggests that in addition to being able to
initiate asymmetric cytoskeletal reorganization, GPR124 signaling also triggers
a general enhancement in cell motility. GPR124þ cells were also found to mi-
grate towards VEGF-depleted CM, demonstrating that GPR124-mediated che-
motaxis is independent from VEGF-mediated chemotaxis, a widely studied li-
gand of endothelial cells and a common cancer drug target. GPR124þ cells
did not chemotax towards CM of 193T cells, a negative control kidney cell
line. These results demonstrate utility of a new quantitative microfluidic platform
to identify novel receptor-ligand partners for potential cancer drug development.
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Mobility of G Proteins is Heterogeneous and Polarized During Chemotaxis
Freek van Hemert, Milena Lazova, B. Ewa Snaar-Jagalska,
Thomas Schmidt.
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The interaction of G-protein-coupled receptors with G proteins is a key event in
transmembrane signal transduction leading to vital decision-taking of the cell.
Here we applied single-molecule epifluorescence microscopy to study the mo-
bility of both the Gbg and the Ga2 subunits of the G protein heterotrimer in
comparison to the cAMP-receptor responsible for chemotactic signaling in Dic-
tyostelium discoideum. Our experimental results suggest that ~30% of the
G protein heterotrimers exist in receptor pre-coupled complexes. Upon stimu-
lation in a chemotactic gradient this complex dissociates, subsequently leading
to a linear diffusion/collision amplification of the external signal. The further
observation of partial immobilization and confinement of Gbg in an agonist,
F-actin and Ga2-dependent fashion led to the hypothesis of functional nano-
metric domains in the plasma membrane that locally restrict the activation sig-
nal and in turn lead to faithful and efficient chemotactic signaling.2578-Pos
Physical Properties of Fibrinogen Substrates Control Integrin Mediated
Cell Adhesion
Ivan Yermolenko1, Alexander Fuhrmann2, Tatiana Ugarova1, Robert Ros2.
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The physical properties of substrates are known to control cell adhesion via in-
tegrin-mediated signaling. Recently, we have shown that binding of fibrinogen
to the surface of fibrin gel prevents integrin aMb2-mediated leukocyte adhesion
by creating an anti-adhesive layer. Furthermore, fibrinogen immobilized on
various surfaces at high density supports weak cell adhesion whereas at low
density it is highly adhesive.
To gain an understanding of the mechanism underlying differential cell adhe-
sion, we extended the cell adhesion assays to platelets carrying integrin aIIbb3.
The results showed a similar behavior indicating that the process is independent
of the type of integrins. In order to quantify the adhesion forces, we applied sin-
gle cell force spectroscopy (SCFS). In this assay, a single cell is attached to
a tipless cantilever of an atomic force microscope (AFM) and force-distance
curves for different surfaces are acquired. For cells carrying aMb2-integrins
we found significant lower adhesion forces for high- compared to low-density
fibrinogen substrates.
Furthermore, we analyzed the adhesive behavior of fibrinogen surfaces using
force spectroscopy with a silicon nitride AFM tip. These experiments, unrelated
to the cells and integrins, show similar behaviors as the cell adhesion assays.
AFM images of the different substrates indicate that fibrinogen deposition at
high density results in an aggregated multilayered material characterized by
low adhesion forces. However, low-density fibrinogen produces a single layer
in which molecules are directly attached to the solid surface resulting in higher
adhesion forces.
The data suggest that deposition of a multilayered fibrinogen matrix prevents
stable cell adhesion by modifying the physical properties of surfaces resulting
in reduced force generation with implications for hemostasis and biomaterial
applications.
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Mechanochemical Signaling in Glomerular Podocytes
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Kidney glomeruli function as filters, allowing the passage of small solutes and
waste products into the urinary space, while retaining essential proteins and
macromolecules in the blood stream. They achieve this through a filtration ap-
paratus comprised of three layers, a fenestrated glomerular endothelium, a base-
ment membrane (GBM) and an epithelial cell layer. Glomerular epithelial cells
(podocytes) culminate into interdigitating foot processes (FPs) between adja-
cent cells. Specialized structures known as slit diaphragms (SDs) function as
modified adherens junctions connecting podocyte foot processes. These struc-
tures are under constant mechanical stress due to fluid pressure, driving filtra-
tion across the barrier. Disruption of the SDs or podocyte damage can lead to
progressive loss of protein into the urine (proteinuria) and ultimately to kidney
failure. Dysregulation of the podocyte actin cytoskeleton has been implicated in
mechanisms of proteinuria.
Podocyte adhesion on collagen activates the FAK/ERK pathway, a known me-
diator of F-actin assembly. Here, we mechanically stimulated adherent podo-
cytes using a cell stretcher. A 20% strain at 1 Hz for 20 min increased ERK
phosphorylation compared to control. We observed a peak after 2 min and
thereafter an exponential decrease. This suggests that podocytes are responsive
to early external strain, which might be transduced into a chemical signal capa-
ble of modulating the actin cytoskeleton. We hypothesize that adhesion via in-
tegrin receptors triggers mechanochemical signals which may in turn affect
cell-cell and cell-GBM connections. Currently, we are studying the effects of
cytoskeletal organization/regulation in wildtype and mutated podocytes, with
a focus on determining cell mechanical properties using magnetic tweezers
and atomic force microscopy.
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Atherosclerosis is a progressive disease characterized in particular by the accu-
mulation of lipids and fibrous elements in arteries. Over the past decade,
